Attached files

file filename
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcjazzq42016ex321.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42016ex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42016ex311.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Jazz Pharmaceuticals plcjazzq42016ex231.htm
EX-10.22E - CASH BONUS PLAN OTHER - Jazz Pharmaceuticals plcjazzq42016ex1022e.htm
EX-10.22B - CASH BONUS PLAN U.S. - Jazz Pharmaceuticals plcjazzq42016ex1022b.htm
10-K - ANNUAL REPORT ON FORM 10-K - Jazz Pharmaceuticals plcjazz1231201610k.htm


Exhibit 21.1
Subsidiaries of the Registrant


Name of Subsidiary
State or Jurisdiction of Incorporation or Organization
 
 
 
 
Jazz Pharmaceuticals Ireland Limited
Ireland
Jazz Financing I Designated Activity Company
Ireland
Jazz Capital Limited
Ireland
Jazz Pharmaceuticals, Inc.
Delaware
Celator Pharmaceuticals, Inc.
Delaware
Jazz Pharmaceuticals Europe Holdings Limited
Gibraltar
Jazz Pharmaceuticals France SAS
France
Jazz Pharmaceuticals France Holdings SAS
France
Jazz Pharmaceuticals Lux S.à r.l.
Luxembourg
Gentium S.R.L.
Italy
Jazz Pharmaceuticals Italy S.R.L.
Italy